SCHEMBL25611778

SCHEMBL25611778

CCC1CCC12CCNCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30753305 0.87 TSHR (0.31) —
SCHEMBL14297525 0.79 — —
SCHEMBL38662911 0.77 GNAO1 (0.39) —
SCHEMBL31011814 0.76 — —
SCHEMBL18781617 0.75 TDP1 (0.31) —
SCHEMBL27051178 0.75 ALPL (0.32) —
SCHEMBL22895050 0.74 — —
Hydrochloric Acid SCHEMBL27086567 0.72 — —
SCHEMBL21890586 0.71 GNAI3 (0.30) —
SCHEMBL19159907 0.71 GNAI3 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159446-A1 Methods and Compositions for Targeting Tregs using CCR8 Inhibitors NANJING IMMUNOPHAGE BIOMEDICAL CO., LTD. (CN) 2023-05-25 — — US disclosed
Send feedback